BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION

Clinical trials for BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION explained in plain language.

Never miss a new study

Get alerted when new BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION trials appear

Sign up with your email to follow new studies for BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Trials to join now! 1

New hope for tough leukemia cases: gentler treatment trial opens for elderly

Disease control Recruiting now

This study is testing a combination of a targeted cancer drug (inotuzumab ozogamicin) with lower-intensity chemotherapy and immunotherapy for adults with a type of blood cancer called acute lymphoblastic leukemia (ALL). It focuses on patients aged 60 and older, or younger adults …

Matched conditions: BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION

Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control

Last updated Apr 04, 2026 00:50 UTC

BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION

Get alerted when new BURKITT-LIKE LYMPHOMA WITH 11Q ABERRATION trials appear

New hope for tough leukemia cases: gentler treatment trial opens for elderly